Target intelligence / Profile preview

Transmembrane protein 191A (pseudogene) (TMEM191A)

Target
TMEM191A
Molecular classification
Pseudogene, Processed pseudogene
01

Overview

Transmembrane protein 191A (pseudogene), abbreviated as TMEM191A or TMEM191AP, is a human pseudogene sequence that resembles the functional transmembrane protein 191A gene but does not encode an active protein. Pseudogenes like TMEM191A arise from gene duplication or retrotransposition and normally accumulate mutations that prevent them from being translated into functional proteins[4][5][6]. While most pseudogenes are transcriptionally silent or functionless, some can exert regulatory effects at the RNA level by acting as decoys for microRNAs or by competing for gene regulatory factors, thereby potentially influencing the expression of other genes[1][6]. However, there is currently no evidence that TMEM191A has any confirmed regulatory function, clinical significance, or drug interactions. Its main significance is as a genomic relic, not as a therapeutic target.

Other names
DKFZp434N035TMEM191APTransmembrane protein 191A
02

Biological functions

Potential regulation of gene expression at the RNA level (for example, by acting as a microRNA decoy or through competitive endogenous RNA mechanisms)No known direct protein-coding function
03

Disease associations

No direct, established roles in disease; some pseudogenes can regulate biological networks or participate in disease indirectly, but no evidence specific to TMEM191A

Beyond the preview

Go deeper on Transmembrane protein 191A (pseudogene) (TMEM191A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 191A (pseudogene) (TMEM191A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call